Want to see ENTX full AI Analyst Report?
Total Valuation
Entera Bio has a market cap or net worth of $496.92M. The enterprise value is $71.29.
Market Cap$496.92M
Enterprise Value$71.29
Share Statistics
Entera Bio has 173,141,830 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding173,141,830
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Entera Bio’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -218.81%.
Return on Equity (ROE)-0.87
Return on Assets (ROA)-0.72
Return on Invested Capital (ROIC)-218.81%
Return on Capital Employed (ROCE)-0.84
Revenue Per Employee2.00K
Profits Per Employee-544.71K
Employee Count21
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Entera Bio is ―. Entera Bio’s PEG ratio is 0.00.
PE Ratio―
PS Ratio2133.59
PB Ratio6.84
Price to Fair Value6.84
Price to FCF-11.98
Price to Operating Cash Flow-12.88
PEG Ratio0.00
Income Statement
In the last 12 months, Entera Bio had revenue of 42.00K and earned -11.44M in profits. Earnings per share was -0.25.
Revenue42.00K
Gross Profit0.00
Operating Income-11.53M
Pretax Income-11.44M
Net Income-11.44M
EBITDA-11.41M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was -11.32M and capital expenditures -79.31K, giving a free cash flow of -11.40M billion.
Operating Cash Flow-11.32M
Free Cash Flow-11.40M
Free Cash Flow per Share-0.07
Dividends & Yields
Entera Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.26
52-Week Price Change44.50%
50-Day Moving Average2.01
200-Day Moving Average1.73
Relative Strength Index (RSI)59.41
Average Volume (3m)123.78K
Important Dates
Entera Bio upcoming earnings date is Nov 5, 2026, After Close (Confirmed).
Last Earnings DateAug 7, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Entera Bio as a current ratio of 3.23, with Debt / Equity ratio of 5.85%
Current Ratio3.23
Quick Ratio3.23
Debt to Market Cap<0.01
Net Debt to EBITDA0.58
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Entera Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Entera Bio EV to EBITDA ratio is -7.27, with an EV/FCF ratio of -11.10.
EV to Sales1.98K
EV to EBITDA-7.27
EV to Free Cash Flow-11.10
EV to Operating Cash Flow-11.26
Balance Sheet
Entera Bio has $11.31M in cash and marketable securities with $425.00K in debt, giving a net cash position of $10.88M billion.
Cash & Marketable Securities$11.31M
Total Debt$425.00K
Net Cash$10.88M
Net Cash Per Share$0.06
Tangible Book Value Per Share$0.28
Margins
Gross margin is 0.00%, with operating margin of -27450.00%, and net profit margin of -27235.71%.
Gross Margin0.00%
Operating Margin-27450.00%
Pretax Margin-27235.71%
Net Profit Margin-27235.71%
EBITDA Margin-27164.29%
EBIT Margin-27235.71%
Analyst Forecast
The average price target for Entera Bio is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.00
Price Target Upside339.02% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-100.00%
EPS Growth Forecast-36.92%